A potassium-sparing diuretic is a type of water pill that helps your body get rid of excess sodium and fluid while holding onto potassium, a mineral your heart and muscles need to function properly. This sets them apart from more commonly prescribed diuretics like thiazides and loop diuretics, which flush potassium out along with the extra fluid. Potassium-sparing diuretics are weaker than other water pills on their own, so they’re often used in combination with stronger diuretics or prescribed for specific conditions where protecting potassium levels is especially important.
How They Work in the Kidneys
All potassium-sparing diuretics act on the same stretch of the kidney’s filtering system: the distal tubule and collecting duct, near the end of the process where your kidneys fine-tune what stays in your body and what gets flushed out. In this part of the kidney, sodium is normally reabsorbed back into the bloodstream. That reabsorption creates an electrical gradient that pulls potassium in the opposite direction, out into the urine. Potassium-sparing diuretics interrupt this exchange, keeping sodium (and the water that follows it) moving toward your bladder while reducing the electrical pull that would normally drag potassium out with it.
There are two distinct ways these drugs accomplish this, which is why they’re split into two sub-classes.
Two Sub-Classes With Different Mechanisms
Aldosterone Antagonists
Spironolactone and eplerenone work by blocking the receptor for aldosterone, a hormone your adrenal glands release to tell your kidneys to hold onto sodium. When aldosterone can’t bind to its receptor, the kidneys stop reclaiming as much sodium, and less potassium gets pushed into the urine as a result. These drugs are sometimes called mineralocorticoid receptor antagonists, or MRAs. Beyond their diuretic effect, they have broader benefits in heart failure, which is why they show up frequently in cardiology treatment plans.
Sodium Channel Blockers
Amiloride and triamterene take a more direct route. They physically block the sodium channels (called ENaC channels) in the kidney’s distal tubule, preventing sodium from being reabsorbed. The net effect on electrolytes is very similar to aldosterone antagonists, but the mechanism skips the hormonal pathway entirely. These drugs are most commonly found in combination pills paired with a thiazide diuretic.
Conditions They’re Used For
Potassium-sparing diuretics are prescribed for high blood pressure, heart failure, liver failure, and fluid buildup from various causes. Some are also used for certain kidney conditions, including kidney stones. But the specific sub-class matters when it comes to choosing one.
Aldosterone antagonists have the strongest evidence in heart failure. In patients with heart failure and a reduced pumping ability (called HFrEF), MRAs consistently improve survival, reduce hospitalizations, and lower the risk of sudden cardiac death. The 2022 American Heart Association/American College of Cardiology guidelines give them a strong recommendation for this population. For other types of heart failure where the heart’s pumping strength is preserved or only mildly reduced, MRAs receive a weaker but still favorable recommendation.
Spironolactone is also widely prescribed for conditions driven by excess aldosterone, such as the fluid retention that accompanies liver cirrhosis. In that setting, it directly counteracts the hormonal imbalance causing the problem.
Why They’re Paired With Other Diuretics
Thiazide diuretics are among the most commonly prescribed blood pressure medications, but they frequently cause potassium levels to drop. In one study, 34 percent of patients taking a thiazide had potassium levels below the normal threshold of 3.5 mmol/L. When those patients were switched to combination pills that included a potassium-sparing component, their potassium levels rose from an average of 3.56 to 4.17 mmol/L within two to three weeks and stayed stable over the follow-up period.
This is the most common way you’ll encounter potassium-sparing diuretics in practice. Rather than being prescribed alone, amiloride or triamterene is bundled into a single tablet with a thiazide. The thiazide does the heavy lifting on blood pressure and fluid removal, while the potassium-sparing agent prevents the electrolyte drop that would otherwise occur. It’s a balancing act built into one pill.
The Main Risk: Too Much Potassium
The same property that makes these drugs useful creates their primary danger. By holding onto potassium, they can push levels too high, a condition called hyperkalemia. Normal serum potassium falls between 3.5 and 5.0 mmol/L. Levels above 5.0 are considered elevated, and levels at or above 6.0 mmol/L are a medical emergency that can cause dangerous heart rhythm problems and, in severe cases, cardiac arrest.
Your risk of hyperkalemia goes up significantly if you have reduced kidney function. The kidneys are the primary way your body eliminates excess potassium, so when they aren’t working well, potassium-sparing diuretics can tip the balance quickly. Guidelines from the National Kidney Foundation flag a kidney filtration rate below 30 mL/min as the threshold where these drugs should be used with particular caution, if at all. The American Heart Association guidelines list that same cutoff, along with a starting potassium level of 5.0 or above, as contraindications to beginning an MRA.
The risk compounds when potassium-sparing diuretics are taken alongside other medications that also raise potassium, such as ACE inhibitors or angiotensin receptor blockers. One large meta-analysis found that using an ACE inhibitor, ARB, or potassium-sparing diuretic was associated with 1.6 times greater odds of developing hyperkalemia. People with diabetes, severe heart failure, adrenal insufficiency, or older age are also more vulnerable.
Dietary Cautions While Taking Them
One underappreciated risk involves salt substitutes. Many people with high blood pressure switch from regular table salt to a potassium-enriched salt substitute to lower their sodium intake. For most people this is a reasonable strategy, but for anyone on a potassium-sparing diuretic, it can be dangerous. Multiple cases of life-threatening hyperkalemia have been reported from salt substitute use in people already on medications that impair potassium excretion. Nearly all of those cases involved at least one additional risk factor, such as kidney disease, diabetes, or concurrent use of other potassium-raising drugs.
High-potassium foods like bananas, oranges, potatoes, and tomatoes don’t typically need to be eliminated entirely, but your overall potassium intake matters more when you’re on these medications. If you have kidney disease, the recommended daily potassium intake drops to 2 to 4 grams, compared to the 4.7 grams suggested for the general population by U.S. dietary guidelines.
Side Effects Beyond Potassium
Spironolactone has a unique side effect profile because it doesn’t just block aldosterone receptors. It also interacts with hormone receptors for androgens and progesterone. This can cause breast swelling and tenderness in both men and women. In men, this effect (called gynecomastia) is one of the more common reasons for switching medications. Eplerenone was developed specifically to avoid this problem. It’s more selective for the aldosterone receptor and causes significantly less hormonal disruption, though it tends to be more expensive.
Amiloride and triamterene generally have fewer side effects beyond the hyperkalemia risk. Triamterene can occasionally contribute to kidney stone formation, which is ironic given that other potassium-sparing diuretics are sometimes used to prevent certain types of stones.